This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Haemonetics will acquire Vivasure Medical, an ...
BOSTON, Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San ...
BOSTON, Jan. 9, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
Haemonetics Corporation (NYSE: HAE) on Friday said it will acquire Ireland-based Vivasure Medical Limited, a move aimed at strengthening its position in structural heart and endovascular procedures, ...
Haemonetics (HAE) has not been in the headlines for a single defining event lately, but the stock’s recent performance and current fundamentals still give you a few concrete data points to work with.
Haemonetics is shaking up the large-bore closure space market with the acquisition of Vivasure Medical, the developer of the PerQseal Elite. The acquisition includes an upfront cash payment of $116 ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Haemonetics (HAE), which belongs to the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results